SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,050 | +15.2% | 42 | +44.8% | 0.00% | – |
| Q3 2023 | $3,515 | -12.3% | 29 | -17.1% | 0.00% | – |
| Q2 2023 | $4,008 | -3.1% | 35 | +16.7% | 0.00% | – |
| Q1 2023 | $4,135 | +103275.0% | 30 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 30 | +11.1% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 27 | +285.7% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 7 | -22.2% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 9 | -43.8% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 16 | +77.8% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -100.0% | 9 | -90.0% | 0.00% | -100.0% |
| Q4 2018 | $9,822,000 | -50.2% | 90 | -26.2% | 0.00% | 0.0% |
| Q3 2018 | $19,704,000 | +20.2% | 122 | -1.6% | 0.00% | 0.0% |
| Q2 2018 | $16,390,000 | +78.4% | 124 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,187,000 | +725.4% | 124 | +520.0% | 0.00% | – |
| Q4 2017 | $1,113,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |